While cells derived from uterine and bone cancers were the ones with the higher number of drugs correlated with MAPT expression, only a few drugs did the same for cell lines derived from tumors affecting tissues such as the CNS, colorectal, upper aerodigestive, blood, and esophagus. The gene discussed is MAPT; the disease is bone neoplasm.